Effects of kuntai capsule in combination with hormone replacement therapy on premature ovarian failure and bone metabolism
article
OA: diamond
CC0
AI-generated summary
Kuntai Capsule combined with HRT improved ovarian reserve, hormone levels, and bone metabolism in premature ovarian failure patients more effectively than HRT alone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study evaluates the clinical effectiveness of combining kuntai capsule with hormone replacement therapy (HRT) in treating premature ovarian failure (POF) and its impact on ovarian reserve and bone metabolism. A total of 190 POF patients were randomly assigned to either a control group (n=95) receiving HRT alone (1 mg estradiol valerate tablets and 10 mg dydrogesterone tablets), or an observation group (n=95) receiving a combination of HRT and Kuntai Capsule. After three months of treatment, the observation group showed significantly better ovarian reserve, with a higher overall effective rate (87.37% vs. 71.58%). Hormonal analysis revealed lower follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels, and higher estradiol (E2) levels in the observation group compared to the control. Furthermore, ovarian reserve markers such as anti-Müllerian hormone (AMH) and antral follicle count were also higher in the observation group. Bone metabolism improvements were noted, with higher osteocalcin (OST) and lower bone-specific alkaline phosphatase (BAP) levels. The observation group also had a significantly lower recurrence rate (7.3%) after 24 months, compared to the control group (16.8%). These results suggest that the combination of Kuntai Capsule and HRT offers a promising treatment for POF, improving ovarian function, hormone levels, and bone health while reducing recurrence risk.
Full text
7,529 characters
· extracted from
oa-html
· 2 sections
· click to expand
Abstract
References
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M,
Grymowicz M, Smolarczyk K, Kostrzak A,
Smolarczyk R, Rudnicka E and Meczekalski B.
Autoimmune Diseases in Patients with Premature
Ovarian Insufficiency-Our Current State of
Knowledge. Int J Mol Sci 2021, 22(5).
Wang J, Sun X, Yang Z, Li S, Wang Y, Ren R, Liu Z and Yu
D. Epigenetic regulation in premature ovarian failure:
A literature review. Front Physiol 2022, 13(998424.
Bai X and Wang S. Signaling pathway intervention in
premature ovarian failure. Front Med (Lausanne)
, 9(999440.
Chon SJ, Umair Z and Yoon MS. Premature Ovarian
Insufficiency: Past, Present, and Future. Front Cell
Dev Biol 2021, 9(672890.
Li Z, Qi H, Li Z, Bao Y, Yang K and Min Q. Research
progress on the premature ovarian failure caused by
cisplatin therapy. Front Oncol 2023, 13(1276310.
Wang Y, Jiang J, Zhang J, Fan P and Xu J. Research Progress
on the Etiology and Treatment of Premature Ovarian
Insufficiency. Biomed Hub 2023, 8(1):97-107.
Svejme O, Ahlborg HG, Nilsson JA and Karlsson MK. Early
menopause and risk of osteoporosis, fracture and
mortality: a 34-year prospective observational study
in 390 women. BJOG 2012, 119(7):810-816.
Samak MA, Abdelrahman AA, Samy W, Abdelrahman SA.
Combined Bazedoxifene and Genistein Ameliorate
Ovariectomy-Induced
Hippocampal
Alterations
via
Neuro
Activating CREB/BDNF/TrkB
Signaling
Pathway. Curr Mol Pharmacol.
;16(6):664-681.
Sullivan SD, Sarrel PM and Nelson LM. Hormone
replacement therapy in young women with primary
ovarian insufficiency and early menopause. Fertil
Steril 2016, 106(7):1588-1599.
Zhang S, Wang L, Zhang J, An W and Jia L. The efficacy
and safety of Kuntai capsule combined with
leuprorelin acetate in the treatment of endometriosis:
A protocol for systematic review and meta-analysis.
Medicine (Baltimore) 2021, 100(11):e25080.
Zhang J, Fang L, Shi L, Lai Z, Lu Z, Xiong J, Wu M, Luo
A and Wang S. Protective effects and mechanisms
investigation of Kuntai capsule on the ovarian
function of a novel model with accelerated aging
ovaries. J Ethnopharmacol 2017, 195(173-181.
Gao H, Xia T, Ma R, Zhao ZORC, Wang B, Song X, Liu L,
Han K, Wang G, Fu Y and Hao G. Heyan Kuntai
capsule versus dehydroepiandrosterone in treating
Chinese patients with infertility caused by diminished
ovarian reserve: a multicenter, randomized controlled
trial. J Tradit Chin Med 2017, 37(4):530-537.
Liu FX and Sun Y. Identification of the active ingredients
and pharmacological effects of Kuntai capsules in the
treatment of primary ovarian insufficiency: A review.
Medicine (Baltimore) 2023, 102(21):e33884.
Ma Q, Tan Y and Mo G. Effectiveness of Cotreatment with
Kuntai Capsule and Climen for Premature Ovarian
Failure: A Meta-Analysis. Evid Based Complement
Alternat Med 2020, 2020(4367359.
Zhang X, Zhang L, Xiong L, Liu X, Zhang J, Yu F, Li Y,
Chang W and Chen W. Kuntai capsule for the
treatment of diminished ovarian reserve: A
systematic review and meta-analysis of randomized
controlled trials. J Ethnopharmacol 2024, 329(118167.
Tang X, Huang Q, Wang C, Zhang D, Dong S and Yu C.
Kuntai Capsule Combined With Letrozole on
Gonadal Hormone Levels and Ovarian Function in
Patients With PCOS: A Systematic Review and
Meta-Analysis. Front Endocrinol (Lausanne) 2021,
(789909.
Zhong HZ, Li MY, Yin XL, Bin CL, Zhou SY and Wei SB.
Chinese patent medicines combined with hormone
replacement therapy for premature ovarian failure: A
Bayesian network meta-analysis. Front Med
(Lausanne) 2022, 9(1043390.
Cai L, Zong DK, Tong GQ and Li L. Apoptotic mechanism
of premature ovarian failure and rescue effect of
Traditional Chinese Medicine: a review. J Tradit
Chin Med 2021, 41(3):492-498.
Pargianas M, Salta S, Apostolopoulou K, Lazaros L,
Kyrgiou M, Tinelli A, Malvasi A, Kalogiannidis I,
Georgiou I and Kosmas IP. Pathways Involved in
Premature Ovarian Failure: A Systematic Review of
Experimental Studies. Curr Pharm Des 2020,
(18):2087-2095.
Freitas ATA, Donovan Giraldo AE, Pravatta Rezende G,
Yela DA, Jales RM and Benetti-Pinto CL. Body
composition in women with premature ovarian
insufficiency using hormone therapy and the relation
to cardiovascular risk markers: A case-control study.
Clin Endocrinol (Oxf) 2021, 94(1):111-118.
Polakova M. Specifics of infertility treatment in women
with premature ovarian failure. Ceska Gynekol 2023,
(2):131-134.
Lin J, Li XL, Song H, Li Q, Wang MY, Qiu XM, Li DJ and
Wang L. A general description for Chinese medicine
in treating premature ovarian failure. Chin J Integr
Med 2017, 23(2):91-97.
Chen H, Zhang G, Peng Y, Wu Y, Han X, Xie L, Xu H,
Chen G, Liu B, Xu T, Pang M, Hu C, Fan H, Bi Y,
Hua Y, Zhou Y and Luo S. Danggui Shaoyao San
protects
cyclophosphamide-induced
premature
ovarian failure by inhibiting apoptosis and oxidative
stress through the regulation of the SIRT1/p53
signaling pathway. J Ethnopharmacol 2024,
(117718.
Sato T, Kusuhara A, Kasahara Y, Haino T, Kishi H and
Okamoto A. Follicular development during hormone
replacement therapy in patients with premature
ovarian insufficiency. Reprod Med Biol 2021,
(2):234-240.
Hamoda H and Sharma A. Premature ovarian insufficiency,
early menopause, and induced menopause. Best Pract
Res Clin Endocrinol Metab 2024, 38(1):101823.
Craciunas L, Zdoukopoulos N, Vinayagam S and
Mohiyiddeen L. Hormone therapy for uterine and
endometrial development in women with premature
ovarian insufficiency. Cochrane Database Syst Rev
, 10(10):CD008209.
Ding X, Lv S, Guo Z, Gong X, Wang C, Zhang X and Meng
K. Potential Therapeutic Options for Premature
Ovarian Insufficiency: Experimental and Clinical
Evidence. Reprod Sci 2023, 30(12):3428-3442.
Genazzani AR, Monteleone P, Giannini A and Simoncini T.
Hormone therapy in the postmenopausal years:
considering benefits and risks in clinical practice.
Hum Reprod Update 2021, 27(6):1115-1150.
Li WJ, Xu LZ, Liu HW, Zhang J, Tang LL, Zhou LL,
Zhuang J, Liu Y and Liu XF. [Effects of Kuntai
Capsule and hormone replacement therapy on
cognitive function and mental symptoms of early
postmenopausal women: a randomized controlled
trial]. Zhong Xi Yi Jie He Xue Bao 2010, 8(4):321
Zhou Q, Tao J, Song H, Chen A, Yang H, Zuo M and Li H.
Chinese herbal medicine Kuntai capsule for treatment
of menopausal syndrome: a systematic review of
randomized clinical trials. Complement Ther Med
, 29(63-71.
Liang R, Liu Z, Li P, Fan P, Xu L, Sun X, Peng J, Peng X
and Zhang M. Kuntai capsules improve glucolipid
metabolism in patients with polycystic ovary
syndrome: A randomized, double-blind, placebo
controlled trial. Medicine (Baltimore) 2019,
(39):e16788.
Qi X, Guo Y and Sun L. Effects of Kuntai capsule on breast
pain and vaginal bleeding in postmenopausal women.
Pak J Pharm Sci 2019, 32(5(Special)):2471-2476.
Article Metrics
Abstract
View : 1716 timesPDF Download : 535 times
Refbacks
- There are currently no refbacks.
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK